Multiple myeloma in Niger Delta, Nigeria: complications and the outcome of palliative interventions
Ogbonna Collins Nwabuko,1,2 Elizabeth Eneikido Igbigbi,3 Innocent Ijezie Chukwuonye,4 Martin Anazodo Nnoli5 1Department of Haematology, Federal Medical Center, Umuahia, 2Department of Haematology, College of Health Science, Abia State University, Aba, Abia State, 3Department of Haematology, Blood Tr...
Main Authors: | Nwabuko OC, Igbigbi EE, Chukwuonye II, Nnoli MA |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2017-05-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/multiple-myeloma-in-niger-delta-nigeria-complications-and-the-outcome--peer-reviewed-article-CMAR |
Similar Items
-
Socioeconomic Factors and Survival of Multiple Myeloma Patients
by: Kamal Chamoun, et al.
Published: (2021-02-01) -
Modified dose of melphalan-prednisone in multiple myeloma patients receiving bortezomib plus melphalan-prednisone treatment
by: Se Ryeon Lee, et al.
Published: (2019-11-01) -
Haematopoietic stem cell transplantation as first-line treatment in myeloma: a global perspective of current concepts and future possibilities
by: Catriona Elizabeth Mactier, et al.
Published: (2012-10-01) -
Busulfan and thiotepa as a conditioning regimen for autologous stem cell transplantation in patients with multiple myeloma: A study of the Korean Multiple Myeloma Working Party (KMMWP-1801 study)
by: Ga-Young Song, et al.
Published: (2022-08-01) -
Impact of melphalan day -1 vs day -2 on outcomes after autologous stem cell transplant for multiple myeloma
by: Aimee Merino, et al.
Published: (2024-03-01)